Removal of the 14-day limit for culturing human embryos is one of the main changes in the revised recommendations from the International Society for Stem Cell Research.
A regulatory change initiated during the Obama administration appears set to be put into practice, allowing more than one supplier of cannabis research products.
The Trump-era regulation, which allowed certain studies to be downplayed in the development of environmental regulations, drew sharp criticism from scientists and environmental groups.
Kevin J. Tracey and Christina Brennan | Dec 1, 2020 | 4 min read
As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.
Becoming a neuroscientist with a service dog by your side presents numerous challenges. Joey Ramp, who went back to college to study her own post-traumatic stress disorder, is learning this the hard way.
Conceived as a way to resolve differences between government regulators and academics over the chemical’s effects, the CLARITY-BPA collaboration instead highlights divisions.
The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.
Reshaping how the Endangered Species Act is implemented is seen as a way to streamline bureaucracy, but critics of the plan say it will leave species at greater risk of extinction.
Opponents of the guidelines, which would bar results of many public health studies from use in policy making, include scientific and healthcare organizations.